Skip to main content
Premium Trial:

Request an Annual Quote

For the Unknown

Family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who died on the USS Arizona, the Associated Press reports.

It notes that the Arizona suffered the highest loss of life during the attack on Pearl Harbor as 1,177 people died aboard the ship. While about 900 individuals went down with the ship and remain there, 85 others were buried without being identified, and the AP says that family members of those lost on the Arizona are calling for the identification of those 85 using new DNA analysis techniques, including genetic genealogy.

However, the AP reports that the Defense POW/MIA Accounting Agency has said it may not be practical to do so. Rear Admiral Darius Banaji, the deputy director of the agency, tells it that the agency lacks files for about half of the Arizona missing and has medical records for only about half of those. The military also only has DNA samples from 1 percent of family members of the Arizona missing, it says.

The AP adds that the use of genetic genealogy would require the military to develop new privacy protection policies.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.